Bradley Merrill Thompson

Epstein Becker & Green, P.C.

Brad_M_Thompson_Professional_Headshot_(002).jpgBradley Merrill Thompson is a shareholder in the law firm of Epstein Becker & Green, P.C.  There he counsels software, medical device, and drug companies on a wide range of FDA regulatory issues.  At the firm, Mr. Thompson leads the Medical Device Regulatory and the Digital Health Practices.

For trade associations, Mr. Thompson has served as counsel to AdvaMed and the Continua Health Alliance, as General Counsel to the Combination Products Coalition, mHealth Regulatory Coalition and the CDS Coalition.

Mr. Thompson also serves as Chairman of the Board of EBG Advisors, Inc. Affiliated with the law firm, EBG Advisors is a Washington, DC, based consultancy that takes a multidisciplinary approach to helping health care and life sciences companies navigate the obstacles they face.

He served as a member of a workgroup established under the Food and Drug Administration Safety and Innovation Act (FDASIA) to identify key considerations to improve patient safety and promote innovation in health information technology, including mobile medical applications, co-chairing the Regulations Subcommittee.

Mr. Thompson has taught food & drug law at Indiana University School of Law-Indianapolis and Columbia Law School.  He also has served as Co-Chair of the Food & Drug Law Committee in the American Bar Association and of the Medical Device Committee of FDLI.

He received his B.A. cum laude, and an M.B.A. from the University of Illinois and his J.D. cum laude from The University of Michigan Law School.